Tag Archives: Disease Modifying Therapy

Disease Modifying Therapies in Multiple Sclerosis: Background for General Readers

Multiple sclerosis (MS) is a presumed autoimmune condition of demyelination and often inflammation of the central nervous system. Its evolution is very variable; some patients suffer episodes lasting weeks to months with complete or near complete recovery in between, and … Continue reading

Posted in Inflammatory/ Auto-Immune Diseases, Primer Posts for General Readers | Tagged , | 1 Comment

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Recent studies indicate that higher strength disease modifying therapies (DMTs) may slow disability progression in secondary progressive multiple sclerosis (MS), as well as reduce the number of relapses. There have also been trials in primary progressive MS but these, most … Continue reading

Posted in Inflammatory/ Auto-Immune Diseases | Tagged , , , , | 1 Comment